መነሻ › ኒውሮብላስቶማ › ዲስትሪክት ኦፍ ኮሎምቢያ
በዲስትሪክት ኦፍ ኮሎምቢያ ለኒውሮብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለኒውሮብላስቶማ የሚደረጉ 6 ጥናቶች በዲስትሪክት ኦፍ ኮሎምቢያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በዲስትሪክት ኦፍ ኮሎምቢያ ውስጥ ያሉ ከተሞች
Official study text (English)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06172296Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Children's National Hospital, Washington D.C.
- Childrens National Hospital, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 23 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT07172958Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT04901702A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
18 Months – 40 Years · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2025 · NCT05135975ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።